Atlas Trials

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Clinical trial NCT02361346 · TERMINATED

Trial details

NCT number
NCT02361346
Sponsor
Molecular Templates, Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's B-cell LymphomaLeukemia, Lymphocytic, Chronic, B-CellSmall Lymphocytic LeukemiaDiffuse Large B Cell LymphomaBlood CancerHematological Malignancy
Start date
2015-02-01
Primary completion
2021-03-22
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.